326 related articles for article (PubMed ID: 2550702)
1. Urinary excretion half-life of delta 1-tetrahydrocannabinol-7-oic acid in heavy marijuana users after smoking.
Johansson E; Halldin MM
J Anal Toxicol; 1989; 13(4):218-23. PubMed ID: 2550702
[TBL] [Abstract][Full Text] [Related]
2. Human urinary excretion profile after smoking and oral administration of [14C]delta 1-tetrahydrocannabinol.
Johansson E; Gillespie HK; Halldin MM
J Anal Toxicol; 1990; 14(3):176-80. PubMed ID: 2165199
[TBL] [Abstract][Full Text] [Related]
3. Urinary elimination half-life of delta-1-tetrahydrocannabinol-7-oic acid in heavy marijuana users after smoking.
Johansson EK; Hollister LE; Halldin MM
NIDA Res Monogr; 1989; 95():457-8. PubMed ID: 2561839
[TBL] [Abstract][Full Text] [Related]
4. Urinary excretion profiles of 11-nor-9-carboxy-Delta9-tetrahydrocannabinol: a Delta9-THC-COOH to creatinine ratio study #2.
Fraser AD; Worth D
Forensic Sci Int; 2003 Apr; 133(1-2):26-31. PubMed ID: 12742686
[TBL] [Abstract][Full Text] [Related]
5. Urinary excretion profiles of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in humans after single smoked doses of marijuana.
Huestis MA; Mitchell JM; Cone EJ
J Anal Toxicol; 1996 Oct; 20(6):441-52. PubMed ID: 8889681
[TBL] [Abstract][Full Text] [Related]
6. Combination of liquid chromatography with ultraviolet detection and gas chromatography with electron-capture detection for the determination of delta 9-tetrahydrocannabinol-11-oic acid in urine.
Karlsson L; Roos C
J Chromatogr; 1984 Mar; 306():183-9. PubMed ID: 6325483
[TBL] [Abstract][Full Text] [Related]
7. Temporal indication of marijuana use can be estimated from plasma and urine concentrations of delta9-tetrahydrocannabinol, 11-hydroxy-delta9-tetrahydrocannabinol, and 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid.
Manno JE; Manno BR; Kemp PM; Alford DD; Abukhalaf IK; McWilliams ME; Hagaman FN; Fitzgerald MJ
J Anal Toxicol; 2001 Oct; 25(7):538-49. PubMed ID: 11599597
[TBL] [Abstract][Full Text] [Related]
8. Forensic aspects of the metabolism and excretion of cannabinoids following oral ingestion of cannabis resin.
Law B; Mason PA; Moffat AC; Gleadle RI; King LJ
J Pharm Pharmacol; 1984 May; 36(5):289-94. PubMed ID: 6145762
[TBL] [Abstract][Full Text] [Related]
9. Terminal elimination plasma half-life of delta 1-tetrahydrocannabinol (delta 1-THC) in heavy users of marijuana.
Johansson E; Halldin MM; Agurell S; Hollister LE; Gillespie HK
Eur J Clin Pharmacol; 1989; 37(3):273-7. PubMed ID: 2558889
[TBL] [Abstract][Full Text] [Related]
10. Detection times of marijuana metabolites in urine by immunoassay and GC-MS.
Huestis MA; Mitchell JM; Cone EJ
J Anal Toxicol; 1995 Oct; 19(6):443-9. PubMed ID: 8926739
[TBL] [Abstract][Full Text] [Related]
11. Screening for cannabinoids in blood using EMIT: concentrations of delta-9-tetrahydrocannabinol in relation to EMIT results.
Gjerde H
Forensic Sci Int; 1991; 50(1):121-4. PubMed ID: 1657743
[TBL] [Abstract][Full Text] [Related]
12. Blood cannabinoids. II. Models for the prediction of time of marijuana exposure from plasma concentrations of delta 9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-delta 9-tetrahydrocannabinol (THCCOOH).
Huestis MA; Henningfield JE; Cone EJ
J Anal Toxicol; 1992; 16(5):283-90. PubMed ID: 1338216
[TBL] [Abstract][Full Text] [Related]
13. Passive cannabis smoke exposure and oral fluid testing.
Niedbala S; Kardos K; Salamone S; Fritch D; Bronsgeest M; Cone EJ
J Anal Toxicol; 2004 Oct; 28(7):546-52. PubMed ID: 15516313
[TBL] [Abstract][Full Text] [Related]
14. Marijuana metabolites in urine of man. X. Identification of marijuana use by detection of delta 9-tetrahydrocannabinol-11-oic acid using thin-layer chromatography.
Kanter SL; Hollister LE; Musumeci M
J Chromatogr; 1982 Jan; 234(1):201-8. PubMed ID: 6276425
[TBL] [Abstract][Full Text] [Related]
15. Plasma and urine profiles of Delta9-tetrahydrocannabinol and its metabolites 11-hydroxy-Delta9-tetrahydrocannabinol and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol after cannabis smoking by male volunteers to estimate recent consumption by athletes.
Brenneisen R; Meyer P; Chtioui H; Saugy M; Kamber M
Anal Bioanal Chem; 2010 Apr; 396(7):2493-502. PubMed ID: 20112012
[TBL] [Abstract][Full Text] [Related]
16. Disposition of cannabichromene, cannabidiol, and Δ⁹-tetrahydrocannabinol and its metabolites in mouse brain following marijuana inhalation determined by high-performance liquid chromatography-tandem mass spectrometry.
Poklis JL; Thompson CC; Long KA; Lichtman AH; Poklis A
J Anal Toxicol; 2010 Oct; 34(8):516-20. PubMed ID: 21258613
[TBL] [Abstract][Full Text] [Related]
17. Delta(9)-tetrahydrocannabinol, 11-hydroxy-delta(9)-tetrahydrocannabinol and 11-nor-9-carboxy-delta(9)-tetrahydrocannabinol in human plasma after controlled oral administration of cannabinoids.
Goodwin RS; Gustafson RA; Barnes A; Nebro W; Moolchan ET; Huestis MA
Ther Drug Monit; 2006 Aug; 28(4):545-51. PubMed ID: 16885723
[TBL] [Abstract][Full Text] [Related]
18. Analysis of forensic specimens for cannabinoids. II. Relationship between blood delta 9-tetrahydrocannabinol and blood and urine 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid concentrations.
Moody DE; Monti KM; Crouch DJ
J Anal Toxicol; 1992; 16(5):302-6. PubMed ID: 1338218
[TBL] [Abstract][Full Text] [Related]
19. Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana.
Huestis MA; Henningfield JE; Cone EJ
J Anal Toxicol; 1992; 16(5):276-82. PubMed ID: 1338215
[TBL] [Abstract][Full Text] [Related]
20. Temporal indication of cannabis use by means of THC glucuronide determination.
Mareck U; Haenelt N; Geyer H; Guddat S; Kamber M; Brenneisen R; Thevis M; Schänzer W
Drug Test Anal; 2009 Nov; 1(11-12):505-10. PubMed ID: 20355165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
